Feasibility Study of a Group Intervention for Youth Wellbeing
An Integrated Transdiagnostic Protocol to Support Wellbeing in Adolescents From a Community Impacted by March 15 Attacks: a Randomized Controlled Trial
1 other identifier
interventional
64
1 country
1
Brief Summary
Psychological distress, anxiety and depression are common in adolescence, and even more so following traumatic events. On Friday 15 March 2019, two mosques in Ōtautahi, Christchurch were targeted in an act of terrorism, resulting in 71 people being injured and 51 people being shot dead. This has had widespread repercussions in the Muslim and wider community in Christchurch and New Zealand. Uptake of a response pathway set up by community and district health board groups has been low despite reports of high levels of distress in the adolescent population. The proposed study offers a transdiagnostic group treatment approach (ie. Targeting a broad range of emotional difficulties) for teenagers from a community impacted by the March 15th shootings, incorporating well-evidenced transdiagnostic treatment principles into an Islamic Psychology framework to address the local population's need. We will determine the feasibility and effectiveness of this approach in increasing wellbeing in teenagers. We will run gender-specific treatment groups (8 participants in each group) recruited from the community, with one individual session (for information and consent) and 6 group sessions. We will measure symptoms of emotional difficulties, trauma symptoms and functioning at baseline, end of treatment and at 3 months follow-up. In addition, we will check in weekly with participants to monitor for any increased distress. We will also measure parental distress to explore whether an intervention for adolescents has an impact on parental wellbeing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 9, 2021
CompletedFirst Posted
Study publicly available on registry
September 1, 2021
CompletedStudy Start
First participant enrolled
April 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedMay 16, 2024
May 1, 2024
1.6 years
August 9, 2021
May 14, 2024
Conditions
Outcome Measures
Primary Outcomes (9)
Total problems score
change in total problems score in Strengths and Difficulties Questionnaire (SDQ), self report and parent report.Scored 0-40 with higher scores indicating more problems.
three time points - initial individual session at week 1, final group session at 7 weeks and 3 month follow up (week 19).
Emotional problems subscore
change in emotional problems subscore in Strengths and Difficulties Questionnaire (SDQ), self report and parent report. Score ranges 0-10 with higher scores indicating more emotional difficulties.
three time points - initial individual session at week 1, final group session at 7 weeks and 3 month follow up (week 19).
Trauma symptoms
change in total score of Child Revised Impact of Event Score (8 item ) (CRIES-8) by self report, score range 0-40, higher scores indicate more PTSD symptoms.
three time points - initial individual session at week 1, final group session at 7 weeks and 3 month follow up (week 19).
Somatic Symptom burden
change in somatic symptoms measured using Somatic Symptom Scale (8-item) (SSS-8) self report questionnaire by participants and parents. 5 point Likert scale gives a total score with range 0-32. Cutoff scores identify individuals with low (4-7), medium (8-11), high(12-15), and very high (16-32)somatic symptom burden.
three time points - initial individual session at week 1, final group session at 7 weeks and 3 month follow up (week 19).
Functional assessment
change in function measured using Children's Global Assessment Scale (CGAS) by clinician. Clinicians give a single global score ranging from 0-100 with higher scores indicating better functioning.
three time points - initial individual session at week 1, final group session at 7 weeks and 3 month follow up (week 19).
Time to recruitment
Time in weeks required to enrol 16 participants and hold initial individual session.
Measured before first group session at week 3.
Implementation
measured by use of fidelity scale to rate adherence to planned session content
Each session will be audio-recorded and scored (at individual session at week 1, weekly group sessions weeks 3- 7, and 3 month follow up/week 19)
Psychological flexibility
change in score on Acceptance and Action Questionnaire (AAQ-2), self
three time points - initial individual session at week 1, final group session at 7 weeks and 3 month follow up (week 19).
Awareness of experience
change in score on Awareness Indicator (AI), new measure asking about awareness of thoughts(aql), body sensations, feelings/emotions, and spiritual heart (qalb and ruh)
three time points - initial individual session at week 1, final group session at 7 weeks and 3 month follow up (week 19).
Secondary Outcomes (7)
Parental distress
three time points - initial individual session at week 1, final group session at 7 weeks and 3 month follow up (week 19).
Suicidal risk
three time points - initial individual session at week 1, final group session at 7 weeks and 3 month follow up (week 19).
Participant Wellbeing
at each individual (week 1) and group session (weeks 3-7) and at 3 month follow up (week 19).
Personality traits
three time points - initial individual session at week 1, final group session at 7 weeks and 3 month follow up (week 19).
Attendance rates
recorded at each weekly group session (weeks 3-7) and data collection point (at individual session at week 1, final group session at 7 weeks and 3 month follow up/week 19).
- +2 more secondary outcomes
Study Arms (2)
transdiagnostic group protocol
EXPERIMENTALThe study will run two gender-specific treatment groups (8 participants each) recruited from the community, with one individual session (for information, consent and initial data collection) and 6 group sessions. Both groups will receive the same intervention. A second round of recruitment will run later with anticipated n of 32 in the experimental arm.
Waitlist control
OTHERAt both recruitment rounds, we will recruit 16 young people to receive the same intervention at a later stage. We will ask them to complete data collection at the same timepoints as the experimental arm participants to compare intervention effect size but will offer them the intervention afterwards so they still have access to the group. Data collected from them in the group will be used to assess feasibility and acceptability but not treatment effect size comparison.
Interventions
The individual and group sessions will integrate core principles from Motivational interviewing (provide information, address barriers), Cognitive Behavioural Therapy (psychoeducation regarding emotions, enhancing emotional awareness, cognitive restructuring, behavioural experiments, relaxation) , Acceptance Commitment Therapy (mindfulness, grounding, emotional and body awareness, enhancing cognitive flexibility), and aspects of Islamic psychology.
Eligibility Criteria
You may qualify if:
- All high school enrolled teenagers
- English speaking
- Participants do not need to identify as Muslim but will be made aware that the protocol incorporates elements of the Muslim faith.
You may not qualify if:
- active psychosis,
- severe substance use,
- intellectual disability
- non-English speaking young people.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Otagolead
- Canterbury Medical Research Foundationcollaborator
Study Sites (1)
Department of Psychological Medicine, University of Otago, Christchurch
Christchurch, Canterbury, 8140, New Zealand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Caroline Bell, MD
University of Otago, Christchurch
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2021
First Posted
September 1, 2021
Study Start
April 10, 2024
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
May 16, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share